Cite
MLA Citation
Ke Su et al.. “Phase III Study on Efficacy and Safety of Triple Combination (Exenatide/Metformin/Biphasic Insulin Aspart) Therapy for Type 2 Diabetes Mellitus.” American journal of therapeutics, vol. 25, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100089301094.0x000022